prof. madya dr. mohd bin makmor bakry

pensyarah farmasi

pejabat dekan fakulti farmasi

No. rasmi:
UKM : 03 8921 5555



   Biografi/ Biography :

  • Graduated with Bachelor Degree in Pharmacy from Universiti Kebangsaan Malaysia, Master of Clinical Pharmacy from University Science of Malaysia, and Doctor of Philosophy (Medicine & Therapeutics from University of Glasgow, Scotland, United Kingdom. Research and educational expertise include pharmaceutical care, clinical pharmacy practice, clinical pharmacokinetics, pharmacogenomics, treatment optimisation through enhancement of medication adherence. Pioneer in clinical pharmacy education and training in Malaysia. Recipient of Anugerah Akademik Negara 2017 (National Academic Award) for teaching excellent in health sciences. More than 80 journal articles were published related to the expertise. Delivered more than 25 invited talks as keynote, plenary and invited speaker in local and international conferences. Lead various research projects with total value of more than RM1.5 million. Supervised many master`s and PhD`s students in related field of interest.

  • fei yee lee, farida islahudin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, mohd makmor-bakry.  (2022).  adverse drug reactions of antihypertensives and cyp3a5*3 polymorphism among chronic kidney disease patients.  - frontiers in pharmacology.  1-8. 

     

    jian lynn lee, shamin mohd saffian, mohd makmor-bakry, farida islahudin, hamidah alias, adli ali, noraida mohamed shah.  (2022).  prescribing practices of intravenous immunoglobulin in tertiary care hospitals in malaysia: a need for a national guideline for immunoglobulin use.  - frontiers in pharmacology.  1-11. 

     

    sareneya dashni rajahthurai, muhammad junaid farrukh, mohd makmor-bakry, hui jan tan, omotayo fatokun, shamin mohd saffian and diana laila ramatillah.  (2022).  use of complementary and alternative medicine and adherence to medication therapy among stroke patients: a meta-analysis and systematic review.  - frontiers in pharmacology.  1-15. 

     

    fei yee lee, farida islahudin, aina yazrin ali nasiruddin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, nurul ain mohd tahir, mohd makmor-bakry.  (2021).  effects of cyp3a5 polymorphism on rapid progression of chronic kidney disease: a prospective, multicentre study.  - journal of personalized medicine.  1-14. 

     

    adliah mhd ali, chandini menon premakumar, mohd makmor bakry.  (2021).  adakah produk kesihatan yang anda beli berdaftar?.  - 1-2. 

     

    fei yee lee, farida islahudin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, mohd makmor-bakry.  (2022).  adverse drug reactions of antihypertensives and cyp3a5*3 polymorphism among chronic kidney disease patients.  - frontiers in pharmacology.  1-8. 

     

    sareneya dashni rajahthurai, muhammad junaid farrukh, mohd makmor-bakry, hui jan tan, omotayo fatokun, shamin mohd saffian and diana laila ramatillah.  (2022).  use of complementary and alternative medicine and adherence to medication therapy among stroke patients: a meta-analysis and systematic review.  - frontiers in pharmacology.  1-15. 

     

    jian lynn lee, shamin mohd saffian, mohd makmor-bakry, farida islahudin, hamidah alias, adli ali, noraida mohamed shah.  (2022).  prescribing practices of intravenous immunoglobulin in tertiary care hospitals in malaysia: a need for a national guideline for immunoglobulin use.  - frontiers in pharmacology.  1-11. 

     

    fei yee lee, farida islahudin, aina yazrin ali nasiruddin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, nurul ain mohd tahir, mohd makmor-bakry.  (2021).  effects of cyp3a5 polymorphism on rapid progression of chronic kidney disease: a prospective, multicentre study.  - journal of personalized medicine.  1-14. 

     

    jian lynn lee, noraida mohamed shah, mohd makmor-bakry, farida islahudin, hamidah alias, shamin mohd saffian.  (2021).  a systematic review of population pharmacokinetic analyses of polyclonal immunoglobulin g therapy.  - international immunopharmacology.  1-11. 

     

    muhammad junaid farrukh, mohd makmor-bakry, ernieda hatah, tan hui jan.  (2021).  impact of complementary and alternative medicines on antiepileptic medication adherence among epilepsy patients.  - bmc complementary medicine and therapies.  1-9. 

     

    yee liew, francis r capule, mohd makmor-bakry.  (2021).  effects of genetic polymorphisms of abcb1 on the efficacy of anesthetic and analgesic agents: a systematic review.  - pharmacogenomics.  1099-1106. 

     

    fei yee lee, farida islahudin, mohd makmor-bakry, hin-seng wong, sunita bavanandan.  (2021).  factors associated with the frequency of antihypertensive drug adjustments in chronic kidney disease patients: a multicentre, 2-year retrospective study.  - international journal of clinical pharmacy.  1311-1321. 

     

    qalidah mohamad ali, endang kumolosasi, mohd makmor bakry.  (2021).  effect of fresh soy milk and its compounds on apoptosis in human leukemic cells and peripheral blood mononuclear cells.  - tropical journal of pharmaceutical research.  511-517. 

     

    arif zikri mazlan, marhanis omar, adliah mhd-ali, mohd makmor-bakry.  (2021).  identification of medications that increase fall risk among residents in residential aged care facilities in klang valley, malaysia.  - sains malaysiana.  1057-1063. 

     

    fei yee lee, farida islahudin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, mohd makmor-bakry.  (2022).  adverse drug reactions of antihypertensives and cyp3a5*3 polymorphism among chronic kidney disease patients.  - frontiers in pharmacology.  1-8. 

     

    sareneya dashni rajahthurai, muhammad junaid farrukh, mohd makmor-bakry, hui jan tan, omotayo fatokun, shamin mohd saffian and diana laila ramatillah.  (2022).  use of complementary and alternative medicine and adherence to medication therapy among stroke patients: a meta-analysis and systematic review.  - frontiers in pharmacology.  1-15. 

     

    jian lynn lee, shamin mohd saffian, mohd makmor-bakry, farida islahudin, hamidah alias, adli ali, noraida mohamed shah.  (2022).  prescribing practices of intravenous immunoglobulin in tertiary care hospitals in malaysia: a need for a national guideline for immunoglobulin use.  - frontiers in pharmacology.  1-11. 

     

    fei yee lee, farida islahudin, aina yazrin ali nasiruddin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, nurul ain mohd tahir, mohd makmor-bakry.  (2021).  effects of cyp3a5 polymorphism on rapid progression of chronic kidney disease: a prospective, multicentre study.  - journal of personalized medicine.  1-14. 

     

    mei mei tew, ernieda hatah, faiz arif, muhammad aqiff abdul wahid, mohd makmor-bakry, khairul nizam abdul maulud.  (2021).  geospatial analysis of distribution of community pharmacies and other health care facilities providing minor ailments services in malaysia.  - journal of pharmaceutical policy and practice.  1-11. 

     

    jamia azdina jamal, choong lai yuan, adliah mhd ali, khairana husain, juriyati jalil, malina jasamai and mohd makmor bakry.  (2012).  instrument to assess pharmacists` perception on application of pharmaceutical chemistry subjects in pharmacy practice.  - procedia social and behavioral sciences. 

     

    adliah mhd ali, tee pey chiau, thomas paraidathathu, mohd makmor bakry, nur akmar taha, shariza sahudin, norazrina azmi, endang kumolosasi, siti azdiah abdul aziz.  (2012).  the effectiveness of feedback using video recording as a potential teaching method in communication and counselling among pharmacy students.  - procedia social and behavioral sciences. 

     

    mohd makmor bakry, ernieda md hatah, noraida mohamed shah.  (2020).  penyelidikan kepatuhan terhadap ubat : impak, punca dan penyelesaian.  - 102. 

     

    mohd. makmor bakry, ernieda hatah & noraida mohamed shah.  (2020).  penyelidikan kepatuhan terhadap ubat : impak, punca dan penyelesaian.  - 8. 

     

    mohd. makmor bakry, ernieda hatah & noraida mohamed shah.  (2020).  penyelidikan kepatuhan terhadap ubat : impak, punca dan penyelesaian.  - 8. 

     

    mohd makmor bakry.  (2020).  penuaan sihat dan kesejahteraan.  - 14. 

     

    mohd makmor bakry, ernieda md hatah, noraida mohamed shah.  (2020).  penyelidikan kepatuhan terhadap ubat : impak, punca dan penyelesaian.  - 102. 

     

    adliah mhd ali, chandini menon premakumar, mohd makmor bakry.  (2021).  adakah produk kesihatan yang anda beli berdaftar?.  - 1-2. 

     

    mohd makmor bakry.  (2021).  ambil kisah perihal ubat, perlukah wujud peraturan khas?.  - bernama.  1-4. 

     

    mohd makmor bakry.  (2021).  mengapa guna picagari low dead-volume untuk suntik vaksin covid-19?.  - berita harian.  1. 

     

    mohd makmor bakry.  (2021).  pakar mahu ivermectin dibuktikan secara klinikal.  - berita harian.  1-3. 

     

    mohd makmor bakry.  (2021).  ivermectin dijual dalam talian tidak diluluskan kkm.  - berita harian.  5.